Theratechnologies Inc. (TSE:TH – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$1.72 and traded as high as C$1.77. Theratechnologies shares last traded at C$1.73, with a volume of 12,580 shares trading hands.
Theratechnologies Price Performance
The company has a current ratio of 1.10, a quick ratio of 0.64 and a debt-to-equity ratio of 562.07. The stock has a market cap of C$76.79 million, a price-to-earnings ratio of -9.33, a PEG ratio of -8.50 and a beta of 1.73. The stock has a 50-day moving average price of C$1.72 and a two-hundred day moving average price of C$1.79.
Theratechnologies (TSE:TH – Get Free Report) last announced its quarterly earnings data on Thursday, October 10th. The company reported C$0.09 earnings per share for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. The firm had revenue of C$30.96 million for the quarter. As a group, equities research analysts forecast that Theratechnologies Inc. will post 0.0298643 EPS for the current year.
About Theratechnologies
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Further Reading
- Five stocks we like better than Theratechnologies
- Why Invest in 5G? How to Invest in 5G Stocks
- How Whitestone REIT is Transforming Sunbelt Retail Growth
- Breakout Stocks: What They Are and How to Identify Them
- Top-Performing Non-Leveraged ETFs This Year
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.